Publications 2018

  1. Myeloid Mineralocorticoid Receptor controls inflammatory and fibrotic responses after renal injury via macrophage Interleukin-4 receptor signaling. J Barrera-Chimal, SM. Lechner, S Giraud, S El Moghrabi, S Kaaki, P Kolkhof, T Hauet, F Jaisser. Kidney Int 2018 (accepté).
  2. Endogenous IL-33 contributes to kidney ischemia-reperfusion injury by promoting invariant Natural Killer T-cell recruitment and function. M Ferhat, A Robin, S Giraud, S Sena, JM Goujon, G Touchard, T Hauet, JP Girard, JM Gombert, A Herbelin, A Thierry. 2018 (accepté).
  3. Ischemia/reperfusion-associated tubular cells injury in renal transplantation: Can metabolomics inform about mechanisms and help identify new therapeutic targets? Guellec CB, Largeau B, Bon D, Marquet P, Hauet T. Pharmacol Res. 2018: S1043-6618(17)31247-1. PMID:29309901


Menu principal

Haut de page